Publication Cover
Structural Heart
The Journal of the Heart Team
Volume 4, 2020 - Issue 6
32
Views
0
CrossRef citations to date
0
Altmetric
Opinion

Evaluating the Cost-Effectiveness of Transcatheter Mitral Valve Therapies for the Treatment of Mitral Regurgitation: “To Infinity and Beyond”

, MD, MSc
Pages 482-486 | Received 10 Jun 2020, Accepted 11 Sep 2020, Published online: 20 Oct 2020

References

  • Khavjou OPD, Leib A. Projections of Cardiovascular Disease Prevalence and Costs: 2015–2035: Technical Report. Research Triangle Park, NC: RTI International; 2016.
  • Reynolds MR, Magnuson EA, Lei Y, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol. 2012;60(25):2683–2692. doi:10.1016/j.jacc.2012.09.018.
  • Reynolds MR, Lei Y, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement with a self-expanding prosthesis versus surgical aortic valve replacement. J Am Coll Cardiol. 2016;67(1):29–38. doi:10.1016/j.jacc.2015.10.046.
  • Baron SJ, Wang K, House JA, et al. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk. Circulation. 2019;139(7):877–888. doi:10.1161/CIRCULATIONAHA.118.035236.
  • Maisano F, Torracca L, Oppizzi M, et al. The edge-to-edge technique: a simplified method to correct mitral insufficiency. Eur J Cardiothorac Surg. 1998;13(3):240–5; discussion 245–6. doi:10.1016/S1010-7940(98)00014-1.
  • Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364(15):1395–1406. doi:10.1056/NEJMoa1009355.
  • Whitlow PL, Feldman T, Pedersen WR, et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) high risk study. J Am Coll Cardiol. 2012;59(2):130–139. doi:10.1016/j.jacc.2011.08.067.
  • Reynolds M, Galper BZ, Apruzzese P, et al. TCT-786 cost effectiveness of the MitraClip compared with mitral valve surgery: 12-month results from the EVEREST II randomized controlled trial. J Am Coll Cardiol. 2012;60(17):B229. doi:10.1016/j.jacc.2012.08.831.
  • Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association task force on performance measures and task force on practice guidelines. J Am Coll Cardiol. 2014;63(21):2304–2322. doi:10.1016/j.jacc.2014.03.016.
  • Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363(17):1597–1607. doi:10.1056/NEJMoa1008232.
  • Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510.
  • Reynolds MR, Magnuson EA, Wang K, et al. Cost effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the PARTNER trial (Cohort B). Circulation. 2012;125(9):1102–1109. doi:10.1161/CIRCULATIONAHA.111.054072.
  • Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289. doi:10.1016/j.jacc.2017.03.011.
  • Moss RR, Humphries KH, Gao M, et al. Outcome of mitral valve repair or replacement: a comparison by propensity score analysis. Circulation. 2003;108 Suppl 1:II90–7.
  • Shuhaiber J, Anderson RJ. Meta-analysis of clinical outcomes following surgical mitral valve repair or replacement. Eur J Cardiothorac Surg. 2007;31(2):267–275. doi:10.1016/j.ejcts.2006.11.014.
  • Acker MA, Parides MK, Perrault LP, et al. Mitral-valve repair versus replacement for severe ischemic mitral regurgitation. N Engl J Med. 2014;370(1):23–32. doi:10.1056/NEJMoa1312808.
  • Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation. J Am Coll Cardiol. 2007;49(22):2191–2201. doi:10.1016/j.jacc.2007.02.043.
  • Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. N Engl J Med. 2018;379(24):2307–2318. doi:10.1056/NEJMoa1806640.
  • Baron SJ, Wang K, Arnold SV, et al. Cost-effectiveness of transcatheter mitral valve repair versus medical therapy in patients with heart failure and secondary mitral regurgitation: results from the COAPT trial. Circulation. 2019;140(23):1881–1891. doi:10.1161/CIRCULATIONAHA.119.043275.
  • Lubitz J, Cai L, Kramarow E, Lentzner H. Health, life expectancy, and health care spending among the elderly. N Engl J Med. 2003;349(11):1048–1055. doi:10.1056/NEJMsa020614.
  • Tam DY, Qiu F, Elbaz-Greener G, et al. Predictors of cumulative health care costs associated with transcatheter aortic valve replacement in severe aortic stenosis. Can J Cardiol. 2020;36(8):1244–1251.
  • Obadia JF, Messika-Zeitoun D, Leurent G, et al. Percutaneous repair or medical treatment for secondary mitral regurgitation. N Engl J Med. 2018;379(24):2297–2306. doi:10.1056/NEJMoa1805374.
  • Nishimura RA, Bonow RO. Percutaneous repair of secondary mitral regurgitation - a tale of two trials. N Engl J Med. 2018;379(24):2374–2376. doi:10.1056/NEJMe1812279.
  • Grayburn PA, Sannino A, Packer M. Proportionate and disproportionate functional mitral regurgitation: a new conceptual framework that reconciles the results of the MITRA-FR and COAPT trials. JACC Cardiovasc Imaging. 2019;12(2):353–362. doi:10.1016/j.jcmg.2018.11.006.
  • Pibarot P, Delgado V, Bax JJ. MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results. Eur Heart J Cardiovasc Imaging. 2019;20(6):620–624. doi:10.1093/ehjci/jez073.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.